ClinicalTrials.Veeva

Menu

Low Grade Serous Ovarian Carcinoma and Uterine Involvement : Should Hysterectomy be the Rule (LOGYST)

Civil Hospices of Lyon logo

Civil Hospices of Lyon

Status

Completed

Conditions

Serous Ovarian Carcinoma
Low Grade Serous Ovarian Carcinoma

Treatments

Other: Rate of myometrial involvement in the population of 28 low grade serous ovarian carcinoma.

Study type

Observational

Funder types

Other

Identifiers

NCT05741554
69HCL23_0175 (Other Identifier)
22-5035

Details and patient eligibility

About

Investigators studied a population of 28 low grade serous ovarian carcinoma treated in Hospices civils de Lyon between 2000 and 2022. The primary objective is to determinate the rate of myometrial involvement by the cancer at pathology examination. Then, investigators compared patients with or without myometrial involvement : survival parameters, predictive factors of myometrial involvement (age, CA 125 level, surgery characteristics, pathology characteristics).

Enrollment

28 patients

Sex

Female

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

  • Inclusion Criteria :

    • 18 years old or more
    • low grade serous ovarian cancer (MDACC classification)
    • Grade 1 serous ovarian carcinoma (Silverberg classification)
  • Exclusion Criteria :

    • no sufficient data available
    • grade 2 and 3 serous ovarian carcinoma

Trial design

28 participants in 2 patient groups

Myometrial involvement
Description:
Myometrial involvement by cancer metastasis after pathology examination
Treatment:
Other: Rate of myometrial involvement in the population of 28 low grade serous ovarian carcinoma.
No myometrial involvement
Description:
Absence of myometrial involvement by cancer metastasis after pathology examination
Treatment:
Other: Rate of myometrial involvement in the population of 28 low grade serous ovarian carcinoma.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems